Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Carl Icahn, Dan Loeb, Irhythm Technologies Inc (IRTC), Babcock & Wilcox Enterprises Inc (BW), Brookdale Senior Living, Inc. (BKD), and More

Icahn Says He Has a Large Position in Rubbermaid Maker Newell, Calls Stock ‘Undervalued’ (CNBC)
Billionaire Carl Icahn said he has a large position in Rubbermaid parent Newell Brands. “I believe Newell itself is undervalued and that’s why I bought it,” the investor told CNBC’s Scott Wapner on Thursday. The investor said he believes he has among the largest positions on Wall Street in the stock, though less than a 5 percent stake. Icahn joins other activist investors including Starboard Value and Martin Franklin in their bid to reform the company. CNBC previously reported that Starboard and Franklin are teaming up to oust Newell’s entire board.

Hedge fund billionaire Dan Loeb is Losing Money on Consumer and Tech Stocks (Business Insider)
LONDON – Third Point‘s Offshore Fund has had a rocky start to 2018. The hedge fund set up by US billionaire investor Daniel Loeb has gained just 0.7% so far in 2018, according to a filing in the UK on Friday. That’s less than the 1.8% overall rise in the S&P 500 stock market benchmark since the start of the year. The fund lost 3% in February, beating the 3.7% downturn in the S&P 500. “February performance was primarily driven by negative performance in core long equity positions across several sectors including Consumer, Healthcare, and TMT,” the fund said in a statement. “Short equity positions generated positive returns. Asset-backed securities contributed the majority of gains in Credit.”

Insider Trading, NYSE, Markets, Stock Trader On The Phone

Image By Monkey Business – Adobe

Carl Icahn Just Dunked on Bill Ackman to End One of the Most High-Profile Hedge Fund Spats in Recent Memory (Business Insider)
Billionaire investor Carl Icahn is reveling in his victory over Pershing Square’s Bill Ackman. Five years ago, the two investors publicly butted heads over the future of supplement maker Herbalife. Icahn was long on Herbalife, whereas Ackman was short, predicting the stock would hit zero. But it didn’t. In fact, the stock is up more than 120% over the last five years. On Wednesday, Pershing Square gave up, exiting from its $1 billion Herbalife short position. As reported by the Wall Street Journal, the failed bet likely cost the firm hundreds of millions of dollars. In an interview with CNBC Thursday, Icahn took the opportunity to gloat, saying, “I enjoy a good fight, especially when I win it.” Icahn says he made $1 billion off of his position in Herbalife.

Deason Sues Xerox to Allow New Board Nominations (Reuters)
(Reuters) – Hedge fund manager Darwin Deason filed a new lawsuit against Xerox Corp (XRX.N) on Friday after it refused to allow him to make nominations to its board after a deadline, the latest blows in a row over its proposed merger with Fujifilm Holdings Corp (4901.T). Deason said on Monday he had the right to nominate directors, despite missing a deadline, because the current board had made a series of significant decisions and disclosures to stockholders after the deadline. Xerox earlier on Friday said Deason did not have the right to nominate directors outside of the nomination window.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.